100 related articles for article (PubMed ID: 22513212)
21. Analysis of Risk Factors for Changes in the Renal Two-Dimensional Image in Gout Patients.
Dang W; Xu X; Luo D; Luo H; Hu J; Zhou J; Liu J; You L
Int J Gen Med; 2021; 14():6367-6378. PubMed ID: 34675606
[TBL] [Abstract][Full Text] [Related]
22. The risk and severity of stroke in patients with atrial fibrillation and gout: A National Representative Database study.
Haddadin F; Arevalo AB; Jabri A; Beydoun H; Fram F; Munoz Estrella A; Karim S; Virani S; Ali Y
J Arrhythm; 2021 Apr; 37(2):394-399. PubMed ID: 33850581
[TBL] [Abstract][Full Text] [Related]
23. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update.
Borghi C; Domienik-Karłowicz J; Tykarski A; Widecka K; Filipiak KJ; Jaguszewski MJ; Narkiewicz K; Mancia G
Cardiol J; 2021; 28(1):1-14. PubMed ID: 33438180
[No Abstract] [Full Text] [Related]
24. Gout inheritance in an extended Chinese family analyzed by whole-exome sequencing: A case-report.
Yang P; Pi X; Marion TN; Wang J; Wang G; Xie Y; Xie D; Liu Y
Medicine (Baltimore); 2020 Jun; 99(25):e20057. PubMed ID: 32569156
[TBL] [Abstract][Full Text] [Related]
25. A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney Transplantation.
Li JW; Suh M; Brigham MD; Kent JD; LaMoreaux B; Johnson RJ; Mandell BF; Hadker N; Sanchez H; Francis K; Miyasato G
Ann Transplant; 2020 Apr; 25():e920553. PubMed ID: 32284525
[TBL] [Abstract][Full Text] [Related]
26. Association between palliative care and end-of-Life care for patients with hematological malignancies: A population-based study.
Chiang JK; Lee YC; Kao YH
Medicine (Baltimore); 2019 Oct; 98(40):e17395. PubMed ID: 31577748
[TBL] [Abstract][Full Text] [Related]
27. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
[TBL] [Abstract][Full Text] [Related]
28. The Role of a "Treat-to-Target" Approach in the Long-Term Renal Outcomes of Patients with Gout.
Kim WJ; Song JS; Choi ST
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31330801
[No Abstract] [Full Text] [Related]
29. Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study.
Chiang JK; Chen JS; Kao YH
BMC Nephrol; 2019 Jul; 20(1):265. PubMed ID: 31311518
[TBL] [Abstract][Full Text] [Related]
30. Study of epidemiological aspects of hyperuricemia in Poland.
Kostka-Jeziorny K; Widecka K; Tykarski A
Cardiol J; 2019; 26(3):241-252. PubMed ID: 31225633
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: A national study.
Mohammed E; Browne LD; Kumar A U A; Adeeb F; Fraser AD; Stack AG
PLoS One; 2019; 14(1):e0210487. PubMed ID: 30682034
[TBL] [Abstract][Full Text] [Related]
32. Urinary Uromodulin/Creatinine Ratio as a Potential Clinical Biomarker for Chronic Kidney Disease Patients with Gout: A Pilot Study.
Wu CH; Yang CC; Chang HW; Huang B; Chen CJ; Lin EI; Wu CY; Chung YH; Hsu YH; Lee CT; Chuang FR
Med Princ Pract; 2019; 28(3):273-279. PubMed ID: 30636243
[TBL] [Abstract][Full Text] [Related]
33. Urinary Metabolomics Study of Patients with Gout Using Gas Chromatography-Mass Spectrometry.
Li Q; Wei S; Wu D; Wen C; Zhou J
Biomed Res Int; 2018; 2018():3461572. PubMed ID: 30410926
[TBL] [Abstract][Full Text] [Related]
34. Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study.
Roughley M; Sultan AA; Clarson L; Muller S; Whittle R; Belcher J; Mallen CD; Roddy E
Arthritis Res Ther; 2018 Oct; 20(1):243. PubMed ID: 30376864
[TBL] [Abstract][Full Text] [Related]
35. Urate-lowering treatment and risk of total joint replacement in patients with gout.
Kuo CF; Chou IJ; See LC; Chen JS; Yu KH; Luo SF; Hsieh AH; Zhang W; Doherty M
Rheumatology (Oxford); 2018 Dec; 57(12):2129-2139. PubMed ID: 30060176
[TBL] [Abstract][Full Text] [Related]
36. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
[TBL] [Abstract][Full Text] [Related]
37. Managing Gout in the Patient with Renal Impairment.
Pascual E; Sivera F; Andrés M
Drugs Aging; 2018 Apr; 35(4):263-273. PubMed ID: 29435850
[TBL] [Abstract][Full Text] [Related]
38. Predictors of high healthcare costs in elderly patients with liver cancer in end-of-life: a longitudinal population-based study.
Chiang JK; Kao YH
BMC Cancer; 2017 Aug; 17(1):568. PubMed ID: 28836965
[TBL] [Abstract][Full Text] [Related]
39. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.
Bardin T; Richette P
BMC Med; 2017 Jul; 15(1):123. PubMed ID: 28669352
[TBL] [Abstract][Full Text] [Related]
40. Association Between Gout and Aortic Stenosis.
Chang K; Yokose C; Tenner C; Oh C; Donnino R; Choy-Shan A; Pike VC; Shah BD; Lorin JD; Krasnokutsky S; Sedlis SP; Pillinger MH
Am J Med; 2017 Feb; 130(2):230.e1-230.e8. PubMed ID: 27720853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
